Advanced/Metastatic Melanoma
3 clinical trials · Condition
◉ Watch Advanced/Metastatic Melanoma
| Record | Firm | Date |
|---|---|---|
| Efficacy, Safety, and Tolerability of Gebasaxturev (V937) Administered Intravenously or Intratumorally With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone in Participants With Advanced/Metastatic Melanoma (V937-011) (NCT04152863) | Merck Sharp & Dohme LLC | 2020-06-05 |
| Cabozantinib and Pembrolizumab for Advanced Metastatic Melanoma (NCT03957551) | John Rieth | 2019-08-27 |
| Study of TAK-733 in Adult Patients With Advanced Nonhematologic Malignancies (NCT00948467) | Millennium Pharmaceuticals, Inc. | 2009-12-01 |
Track Advanced/Metastatic Melanoma automatically
Every clearance here is in the API, with alerts when new ones post.